Aqualung Therapeutics Corporation
PrivateLast Round
Grant
Sep 15, 2025
Total Funding Raised
$14.93M
Company Overview
Aqualung Therapeutics Corporation operates in Healthcare & Life Sciences and is based in Tucson, Arizona. Its latest recorded funding round was a Grant round in September 2025.
Aqualung Therapeutics Corporation is a biotechnology company that develops an immune-focused biologic platform for serious inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqualung Therapeutics Corporation Comparables
Compare Aqualung Therapeutics Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Respana Therapeutics, Inc. | 87% | |
| Implicit Bioscience | 83% | |
| BioAegis Therapeutics | 81% |
For institutional investors. Book with your work email.
Aqualung Therapeutics Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2025 | ||||
| Series A Extension | Jul 18, 2023 | ||||
| Series A | Oct 1, 2022 | ||||
| Grant | Sep 21, 2022 | ||||
| Convertible Debt | Jan 18, 2022 | ||||
Grant | Jun 2, 2020 |
For institutional investors. Book with your work email.
Aqualung Therapeutics Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Florida Venture Forum | Series A Extension |
| JSR Life Sciences | Convertible Debt, Series A |
| DeepWork Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Monthly visitors grew 108% MoM, reaching 1.9K.
- Sep 15, 2025
$1.2M grant received from NIH RADx.
For institutional investors. Book with your work email.
Aqualung Therapeutics Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aqualung Therapeutics Corporation's valuation, stock price, and market status.
Is Aqualung Therapeutics Corporation a public or private company?
Aqualung Therapeutics Corporation is a private company.
What is the current stock price of Aqualung Therapeutics Corporation?
Aqualung Therapeutics Corporation is a private company, so its shares have no public market price. Caplight tracks Aqualung Therapeutics Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aqualung Therapeutics Corporation worth (valuation)?
Valuation information for Aqualung Therapeutics Corporation is not publicly available.
Can I buy Aqualung Therapeutics Corporation stock?
Aqualung Therapeutics Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aqualung Therapeutics Corporation's last funding round?
Aqualung Therapeutics Corporation's most recent funding round was Grant on September 15, 2025.
Who are the main investors in Aqualung Therapeutics Corporation?
Key investors in Aqualung Therapeutics Corporation include JSR Life Sciences.
Will Aqualung Therapeutics Corporation IPO soon?
No public IPO plans have been announced for Aqualung Therapeutics Corporation.
How can I track Aqualung Therapeutics Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Aqualung Therapeutics Corporation's shares on secondary markets.